Open Access Open Access  Restricted Access Subscription or Fee Access

Should the HHS Decision to Overrule FDA on Plan B Be Reversed

Peter J. Pitts


On December 7, 2011, Secretary of Health and Human Services Kathleen Sebelius overruled a decision of the Food and Drug Administration (FDA) on the over-the-counter (OTC) status of emergency contraception.

What will be the repercussions of Secretary Sebelius’s action? Why is the act itself of far greater long-term significance than the transitory regulatory action it impacts?

By reversing an FDA decision, the Secretary has set a dangerous precedent for all-comers to lobby Congress, the Department of Health and Human Services (HHS) and the White House on any and all FDA decisions—directly inserting politics into what must be a scientifically driven process.


FDA, HHS, Plan B

Full Text:




. refusal-to-relax-plan-brestrictions/2011/12/08/gIQAJSZbfO_story.html


  • There are currently no refbacks.